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ABSTRACT
The production of animals with large transgenes is an in-
creasingly valuable tool in biotechnology and for genetic stud-
ies, including the characterization and manipulation of large
genes and polygenic traits. In the present study, we describe an
intracytoplasmic sperm injection (ICSI) method for the stable
incorporation and phenotypic expression of large yeast artificial
chromosomes (YAC) constructs of submegabase and megabase
magnitude. By coinjecting spermatozoa and YACs into meta-
phase II oocytes, we were able to produce founders exhibiting
germline transmission of an intact and functional transgene of
250 kilobases, carrying the mouse tyrosinase locus, used here
as a reporter gene to rescue the albinism of recipient mice. More
than 35% transgenesis was obtained for this YAC transgene.
When compared with the pronuclear microinjection standard
method, the efficiency of the ICSI-mediated YAC transfer system
was significantly greater. In summary, we describe, for the first
time, stable incorporation in the host genome and correct phe-
notypic expression of large DNA constructs mediated by ICSI.
artificial chromosomes, assisted reproductive technology, early
development, gamete biology, gene regulation, genomic locus,
intracytoplasmic sperm injection, in vitro fertilization, sperm-me-
diated gene transfer, transgene integrity, tyrosinase
INTRODUCTION
The production of transgenic animals, through stable in-
corporation of foreign DNA (transgenes) in the genome of
somatic and germinal cells, generates important organisms
for the study of gene functionality and for biotechnology
purposes. For decades, researchers have been trying to in-
crease construct size without compromising transgenesis
and phenotypic expression. The use of genomic-type con-
structs (bacterial artificial chromosomes [BACs], P1-de-
rived artificial chromosomes [PACs], and yeast artificial
chromosomes [YACs]) in transgenesis has become a valid
approach because the size of their inserts (ranging from
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;100 to more than 1000 kilobases [kb], depending on its
type) usually ensures faithful expression pattern of the
transgene due to the inclusion of most regulatory elements
responsible for the appropriate expression of the gene with-
in these large constructs [1, 2]. Further, the availability of
YAC- and BAC-integrated maps, for the mouse [3] and rat
[4] genomes, along with their corresponding whole-genome
sequences, makes them excellent candidates for gene func-
tion/rescue of mutation-type analyses in transgenic animals
[i.e., 5, 6].
The introduction of YACs into the germline of transgen-
ic animals by conventional, pronuclear (PN) microinjection,
while feasible, remains technically difficult, even though it
was first described 10 yr ago [7, 8]. Other methods have
been described to generate YAC-transgenic animals, such
as lipofection of YAC DNA into embryonic stem [ES] cells
or fusion of yeast cells (spheroplasts) with ES cells (re-
viewed in [1]). However, these two ES cell-mediated meth-
ods require the more time-consuming generation of chi-
meras and, regarding the fusion with yeast cells, the inte-
gration of the entire yeast genome along with the YAC has
to be considered. YAC transgenesis by PN microinjection
typically produces founder mice with an efficiency of ,5%,
which is lower but comparable with that observed with
plasmids [1, 2]. However, the generation of YAC transgenic
mice for a given YAC by PN microinjection is often prob-
lematic (unpublished results), and it is likely to correlate
with DNA batches and purity of YAC DNA samples.
Therefore, the generation of new YAC transgenic animals,
potentially of great scientific value, may have been hin-
dered by currently available, inefficient procedures.
The first indication that exogenous DNA could be intro-
duced into untreated sperm was provided in 1971 [9]. Next,
it was reported that live mouse spermatozoa incubated with
exogenous DNA could result in transgenic offspring [10].
This pioneer study triggered initial contradictory reports
[11] that have fed an intense debate, not yet finished within
the field [12–14]. Ten years later, a new technique desig-
nated metaphase II transgenesis, involving the previously
described methodology of intracytoplasmic sperm injection
(ICSI) [15], was shown to mediate mouse transgenesis at
high efficiency [16]. Interestingly, the regulated damage of
sperm heads (by freeze-thaw cycles or exposure to deter-
gents) was found critical to produce transgenic offspring.
Recently, this method was applied to bacterial and mam-
malian artificial chromosomes (BAC and MAC, respective-
ly) ranging from 11.9 to 170 kb [17]. However, it remained
to be demonstrated that large DNA constructs could be sta-
bly introduced in the mouse genome using sperm as a vec-
tor and that these constructs would be integrated intact. The
1944 MOREIRA ET AL.
use of large DNA constructs (harboring genomic inserts
100–1000 kb in length), such as YACs, increases the prob-
ability of mechanical shearing of DNA and, hence, partial
transgene integration [18, 19]. For this reason, the efficien-
cy of a particular method of transgenesis cannot be fully
evaluated unless it is ascertained the integration of the in-
tact construct in the genome of the host and its transmission
to the offspring.
In this report, we have addressed the use of YACs,
which are capable of mobilizing genomic fragments 100–
2000 kb in length [20, 21], for the efficient production of
transgenic animals with large DNA constructs. Moreover,
we have compared the efficiency of YAC transgenesis by
PN microinjection with that of ICSI-mediated YAC transfer
(IMYT) for a construct of 250 kb. This YAC transgene
carried a functional tyrosinase locus, similar to previous
YAC tyrosinase constructs used for the generation of trans-
genic mice [19]. The tyrosinase gene encodes the key en-
zyme for the biosynthesis of melanin, and its absence or
mutation results in a syndrome known as oculocutaneous
albinism type I. A number of tyrosinase constructs have
been used to rescue the albino phenotype of recipient mice
in transgenic experiments [22], including a standard tyros-
inase construct, used as a reporter gene in animal transge-
nesis [23]. Indeed, the size of the mouse tyrosinase gene,
including regulatory regions (a minimum of 100 kb) [19],
makes it an excellent candidate for reporter purposes of
large constructs because only the integration of the intact
gene is likely to result in a functional transcript, and hence,
pigmentation.
In this study, we describe for the first time stable incor-
poration and phenotypic expression of constructs with sub-
megabase magnitude mediated by ICSI. By coinjecting
spermatozoa and YACs into metaphase II (MII) oocytes,
we were able to produce founders exhibiting germline
transmission of an intact and functional transgene of 250
kb.
MATERIALS AND METHODS
Reagents and Media
All chemicals and media were purchased from Sigma Chemical Co.
(Alcobendas, Madrid, Spain) unless otherwise stated.
Animals
Albino outbred CD1 mice (Harlan Iberica SL, Barcelona, Spain) were
used as donors of oocytes and sperm for ICSI experiments. Females were
6–8 wk old at the time of the experiments, and males at least 3 mo old.
CD1 females were also used for surrogate mothers for embryo-transfer
experiments, mated with vasectomized CD1 males. Lactating CD1 foster
mothers were occasionally used to raise pups. Mice were fed ad libitum
with a standard diet and maintained in a temperature and light-controlled
room (238C, 14L:10D). All animal experiments were performed in accor-
dance with Institutional Animal Care and Use Committee guidelines and
in adherence with guidelines established in the Guide for Care and Use
of Laboratory Animals as adopted and promulgated by the Society for the
Study of Reproduction.
DNA
YAC construct YRT2DLCR (unpublished) was used for IMYT and PN
microinjection. DNA from the C3H mouse strain was used to prepare the
original YRT2 YAC, as reported previously [7, 8]. A detailed description
of YAC YRT2DLCR will be published elsewhere. In brief, deletion of the
LCR fragment [19] was achieved in the YRT2 parental YAC by homol-
ogous recombination techniques in yeast cells, using the pop-in/pop-out
method, as described previously [24]. Thereafter, YAC DNA was prepared
and purified following reported methods [8, 25], resulting in a DNA con-
centration of ;15 ng/ml in YAC-microinjection buffer (10 mM Tris-HCl,
pH 7.5, 0.1 mM EDTA, 100 mM NaCl, 30 mm spermine, and 70 mm
spermidine) [18]. The integrity of YAC DNA preparation was verified by
pulsed-field gel electrophoresis. Subsequently, 1/10 to 1/20 YAC DNA
dilutions in the YAC-microinjection buffer were used for PN microinjec-
tion and 1/4 dilutions for IMYT. The same batch of YAC DNA was used
for PN microinjection and IMYT to eliminate possible differences that
may occur during purification.
The efficiency of transgenesis obtained for this YAC construct was
also compared with that obtained by ICSI-mediated transgenesis of a plas-
mid EGFP (5.4 kb, pEGFP-N1, Clontech Laboratories, Inc., Palo Alto,
CA), containing the human cytomegalovirus immediate early promoter and
the enhanced green fluorescent protein (GFP) gene. EGFP was linearized
with Afl II prior to use.
Gamete Collection, Sperm Freezing, and Transgenic
Mixing
MII oocytes were collected 14 h post-hCG administration, from 6- to
8-wk-old female mice superovulated with 5 IU of equine chorionic go-
nadotropin, followed 48 h later by an equivalent dose of human chorionic
gonadotropin. Cumulus cells were dispersed by a 3- to 5-min incubation
in M2 medium containing 350 IU/ml hyaluronidase, and oocytes washed
and maintained in K1 modified simplex optimized medium (KSOM) [26]
at 378C in a 5% CO2 air atmosphere until use.
Freeze-thawed sperm was prepared essentially as described [27], with
minor differences. Briefly, epididymal sperm from mature (3- to 6-mo-
old) males was collected in M2 medium by excising with a pair of fine
scissors, and compressing with forceps, blood and adipose tissue-free ep-
ididymal caudae. The collected sperm cells, in a minimal volume, were
placed in the bottom of a 1.5-ml polypropylene centrifuge tube and over-
laid with the volume of fresh medium necessary to obtain the final con-
centration of 2.5 million cells per milliliter. The sperm extender used (M2
medium) did not contain Ca21 chelating agents, such as EDTA or EGTA.
After gentle mixing, 70- to 100-ml aliquots of the sperm suspension were
transferred to cryogenic 1.5-ml vials, tightly capped, and directly placed
into liquid nitrogen without complete immersion to avoid internalization
of liquid nitrogen. Sperm samples were stored for periods ranging from 1
day to 4 wk at 2758C. Asepsis was maintained throughout the procedure.
Mixtures of equal volumes (usually 4 ml) of freshly thawed spermatozoa
in M2 and ;4 ng/ml YAC DNA (4–8 ng/ml plasmid EGFP) were kept on
ice for 2 min before being mixed with 40–50 ml of a 10% polyvinyl-
pyrrolidone (PVP; Mr 360 000) in M2 solution and placed in the culture
dish for microinjection.
Embryo Micromanipulation, Culture, and Transfer
Mouse pronuclear injections were performed as previously described
[7, 8, 19, 25]. ICSI-mediated YAC transfer with frozen-thawed sperma-
tozoa was performed in M2 medium at room temperature within 120 min
of sperm-DNA mixing. One volume of sperm-YAC solution was mixed
with five of M2 medium containing 10% PVP to decrease stickiness. The
ICSI dish contained a manipulation drop (M2 medium), a sperm-YAC
drop (sperm-YAC solution in M2/10% PVP), and a M2/10% PVP needle-
cleaning drop. Injections were performed with a PMM-150 FU piezo-
impact unit (Prime Tech, Japan) using a blunt-ended mercury-containing
pipette with 6–7 mm of inner diameter. Individual sperm heads decapitated
by the freeze/thaw procedure were coinjected with adherent YACs into
oocytes. Oocytes were injected in groups of 10. After 15 min of recovery
at room temperature in M2 medium, surviving oocytes were returned to
mineral oil-covered KSOM and cultured at 378C in a 5% CO2 air atmo-
sphere. For full-term development (of both one- and two-cell embryos,
pronuclear injected plasmid, or ICSI-fertilized and pronuclear-injected
YAC), embryos were transferred to oviducts of recipient females. Embryo
transfer was performed as described previously [27, 28].
Analysis of Genomic DNA
Genomic DNA was prepared from tail biopsies following standard pro-
cedures [25] and used for PCR or Southern blot analysis, as described [7,
19]. Oligonucleotides used for detecting the specific 340-base pair (bp)
PCR product of EGFP were GFP1F 59-tgaaccgcatcgagctgaagg-39, GFP2R
59-tccagcaggaccatgtgatcg-3.9 PCR conditions were as follows: Taq poly-
merase (Promega, Madison, WI), 2 min at 938C, 30 cycles of 30 sec at
938C, 45 sec at 608C, and 35 sec at 728C, followed by a final extension
step of 10 min at 728C.
For IMYT experiments, PCR analysis was used for the detection of
yeast markers (TRP1 and LYS2) present in both vector arms of the YAC
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FIG. 1. a) Schematic structure of the injected YAC construct YRT2DLCR
(250 kb). The positions of the yeast markers TRP1 and LYS2, used for PCR
analysis, and of the internal probe 39LCR, used for Southern blot analysis,
are indicated. The small, white circle in the TRP1-containing arm indi-
cates the yeast centromere. The transcription starting point of the tyrosi-
nase gene is shown by a bent arrow, and the five exons that this gene
contains are represented by black rectangles. Site of LCR deletion is also
marked. Scale bar is shown. b) Transgenic (YRT2DLCR, shown in front)
and control albino mice. Note the intense eye pigmentation and patchy
pigmented areas in the ear of the transgenic mouse, as compared with
the albino phenotype of a representative recipient CD1 mouse, shown
behind.
TABLE 1. Embryo cleavage and transgenesis obtained with 5.4-kb (standard plasmid) and 250-kb (YAC) constructs.a
Technique
employeda Construct (size in kb)
Injected oocytes
(no. sessions)
Surviving
oocytes (%)
Two-cell
embryos (%)
Embryos
transferred
(no. reci-
pients)
Live animals
(%)
Live transgenic
animals (%)
ICSI EGFP (5.4) 219b
(6)
195
(78)
167
(86)
163
(8)
22
(13)
10
(45)
IMYT YRT2DLCR (250) 367b
(6)
252
(69)
201
(80)
218c
(13)
34
(16)
12
(35)
PNM YRT2DLCR (250) 1733d
(12)
1219
(70)
959
(79)
959
(44)
93
(10)
1
(1)
a ICSI, Intracytoplasmatic sperm injection; IMYT, ICSI-mediated YAC transfer; PNM, pronuclear microinjection.
b Unfertilized MII oocytes.
c Seventeen surviving one-cell embryos were also transferred.
d Fertilized oocytes.
transgene. Oligonucleotides used for detecting the specific 488-bp or 592-
bp TRP1 and LYS2 PCR products of YAC YRT2DLCR, respectively, were
trp1 59-gcccaatagaaagagaacaattgacc-39, trp2 59-acacctccgcttacatcaacacc-39,
lys1 59-accaagccagcatctgtatcacc-39, and lys2 59-gccaaatccatccacttctcatc-39.
PCR conditions were as follows: AmpliTaq (Roche), 2 min at 948C, 35
cycles of 30 sec at 948C, 30 sec at 658C. and 2 min at 728C, followed by
a final extension step of 10 min at 728C. Genomic DNAs from unrelated
YAC transgenic mice [19, 22] were systematically included as positive
controls for PCR analyses. For Southern blot analysis of YAC transgenes.
the internal 39LCR probe has been reported before (probe E5; [29]) and
results in a Hind III polymorphic pattern that allows clear distinction be-
tween the transgenic YAC DNA (6.5 kb) and the endogenous tyrosinase
locus (1.2 kb).
RESULTS
The same YAC construct, termed YRT2DLCR, with a
size of 250 kb, was used for PN microinjection and IMYT
transgenic experiments (Fig. 1a). In IMYT experiments,
367 MII oocytes were microinjected, 252 (69%) survived
injection, and 201 (80%) cleaved to the two-cell stage. In
PN microinjection experiments, 1733 pronuclear-stage oo-
cytes were microinjected, 1219 (70%) survived injection,
and 959 (79%) cleaved to the two-cell stage. Similar values
were obtained for ICSI assays with a 5.4-kb EGFP standard
transgene (Table 1). The absence of significant differences
in embryo survival and progression to the two-cell stage
suggests that embryo manipulation and the method and tim-
ing of transgene administration do not significantly impact
early embryo viability. Transfer of 163 (EGFP), 218
(IMYT), and 959 (PN microinjection) embryos produced
149 offspring. The integrity of genomic integrants was
evaluated by PCR and Southern blot analysis for
YRT2DLCR and by PCR analysis for EGFP. Of 34 off-
spring generated by IMYT, 12 (35%) were shown to carry
transgene DNA (Table 1). This proportion was significantly
different from that obtained by PN microinjection of
YRT2DLCR, in which only one (;1%) of the 93 offspring
produced by this method carried transgene DNA. Of 22 live
offspring in the EGFP series, 10 (45%) carried the trans-
gene. This efficiency is comparable with that of IMYT.
Considering that EGFP is a transgenic construct about 50
times smaller than YRT2DLCR, the transgenesis obtained
by IMYT becomes even more impressive. It is important
to note that it is the mass (or length) of the DNA, not its
molarity, that is important in ICSI-mediated transgenesis
and predicts the feasibility of introducing megabase-size
transgene constructs [1, 2, 21]. To assess germline trans-
mission, three IMYT-produced founders were crossed with
nontransgenic mice. All transmitted transgene DNA to their
progeny, approximating Mendelian genetics, assuming sin-
gle or closely linked integration sites: founder 1, 12 out of
26; founder 3, 5 out of 15; and founder 6, 11 out of 17
offspring, received the YAC transgene from their respective
transgenic progenitor. Besides the huge difference in size,
this rate of YRT2DLCR germline transmission is compa-
rable with that previously reported for EGFP [16] by an
analogous method, attesting the stability of YAC transgene
integrants. Most of the IMYT-derived transgenic animals
contained integrations of only part of the YAC transgene
construct (Table 2). However, the presence of terminal or
internal markers (alone or in combination) was, in any case,
considerably higher than that in the offspring produced by
PN microinjection, where only a single terminal yeast
marker was detected.
Of the IMYT-derived transgenic offspring, 1/12 (8%),
corresponding to founder 1 (Table 2), apparently harbored
an intact copy of the 250 kb YAC, thus supporting the value
of our improved ICSI-derived methodology for the gener-
ation of transgenic animals with large DNA constructs. This
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TABLE 2. Detection of YRT2DLCR (250-kb YAC transgene) DNA in trans-
genic animals.a
Technique
employeda
Founder
mouse
TRP1 markerb
(PCR)
LYS2 markerb
(PCR)
39LCR probeb
(Southern blot)
IMYT 1c 1 1 1
3
5
6
7
8
1
2
1
1
2
1
2
1
2
2
2
1
2
2
1
9
12
17
25
26
2
2
2
1
1
2
1
2
2
2
1
1
1
2
2
28 1 2 2
PNM 52 1 2 2
a IMYT, ICSI-mediated YAC transfer; PNM, pronuclear microinjection.
b Shown in Figure 1a.
c Shown in Figure 1b.
was confirmed, physically, with three well-separated trans-
gene markers (Fig. 1a and Table 2) and, functionally, by a
coinherited coat color characteristic of tyrosine YAC trans-
gene expression (Fig. 1b). All three YAC transgene-specific
DNA markers and the characteristic pigmented phenotype
were observed in the offspring of founder 1. The YAC
YRT2DLCR construct carries a tyrosinase gene in which
its locus control region (LCR) has been experimentally de-
leted, resulting in variegated expression in skin, coat, and
eyes, as reported previously with analogous YAC con-
structs in mice [28], generated by PN microinjection [8,
19]. This phenotype is recapitulated here as heavily pig-
mented eyes, with clear but low expression in skin (pig-
mented patches can be found in ears) and hair (very light
gray coat color) (Fig. 1b).
Although we are consistently and efficiently able to gen-
erate transgenic offspring via PN microinjection [reviewed
in 22; unpublished results], we were unable to use the PN
microinjection method to produce a YRT2DLCR transgene-
expressing mice.
DISCUSSION
Besides clearly demonstrating YAC transgenesis by
IMYT, the main finding of this study is that ICSI-mediated
transgenesis is a more efficient method to produce stable
incorporation in the host genome and correct phenotypic
expression of large DNA constructs than PN microinjec-
tion. In our opinion, this is likely a function of the relatively
small aperture of PN microinjection pipettes, which is ;10
times narrower than that of IMYT pipettes (7 mm). Larger
pipettes ease handling of, and likely reduce damage to, very
large DNA fragments. We do not have sufficient informa-
tion, however, to explain why PN microinjection did not
produce the higher levels of partial YRT2DLCR integration
observed with IMYT. It is possible that remodeling within
an MII oocyte of a sperm nucleus delivered by ICSI gen-
erates open chromatin and thereby opportunities for large
DNA fragment integration, which do not occur at the pro-
nuclear stage. It is also possible that our modified sperm-
freezing procedure, executed in the absence of calcium-
chelating agents, such as EDTA or EGTA, which inhibit
chromosome damage during freezing [30] and are com-
monly used in conventional ICSI-mediated transgenesis, re-
sults in a higher level of sperm DNA exposure [30] and/or
breakage, which might facilitate transgene DNA integration
(as observed in this study after ICSI-mediated transfer of
YAC YRT2DLCR and plasmid EGFP transgenic con-
structs).
We have here described the high-efficiency introduction
by IMYT of a 250-kb YAC transgene, YRT2DLCR. Ex-
pression of the transgene product, tyrosinase, resulted in the
rescue of the albino background of the host. The pigmented
phenotype was associated with the presence of an intact
copy of the transgene, which was expressed and stably
maintained in the offspring. To our knowledge, this is the
first report that shows intact integration, correct phenotypic
expression, and germline transmission of a construct of sub-
megabase magnitude, such as a YAC, mediated by ICSI.
These data clearly demonstrate the YAC transgenesis by
IMYT. Moreover, they indicate that the ability to generate
functional transgenic animals with large YAC constructs
via ICSI is greater than that of PN microinjection. Most
emphasis should be placed on the fact that only one half
as many sessions and a fifth as many oocytes were needed
to generate 12 IMYT transgenics than the ones used to
generate a single transgenic animal by PN microinjection.
IMYT is poised to enable efficient, reproducible, and stable
integration of even larger DNA constructs that will be of
increasing importance in the manipulation and study of
large genes and gene clusters in biomedicine.
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